Table:
Variables	Patients without potential drug-drug interactions in their prescriptionn = 132	Patients with at least one potential drug-drug interactions in their prescriptionn = 492
Gender (female)	105 (79.5)	386 (78.5)
Civil status (single)	61 (46.2)	259 (52.6)
Did not work	102 (77.3)	416 (84.6)
Literacy (only elementary school o less)	67 (54.9)	266 (62.9)
Patient age ≥ 60*	87 (65.9)	406 (82.5)
Number of disease ≥ 3*	73 (55.3)	396 (80.5)
Cardiovascular disease*	43 (32.6)	403 (81.9)
Musculoskeletal and joint disorders	126 (95.5)	471(95.7)
Gastrointestinal disease	48 (36.4)	205 (41.7)
Endocrine, alimentary and metabolic disease*	38 (28.8)	275 (55.9)
Pulmonary disease	8 (6.0)	31 (6.3)
Mental disease	12 (9.1)	21 (4.3)
Neurological disease	11 (8.3)	40 (8.1)
Infections and parasitic disease	30 (22.7)	88 (17.9)
Number of medicines ≥ 5*	50 (37.9)	383 (77.8)

Interpret the illustration as Markdown format.

| Variables | Patients without potential drug-drug interactions in their prescriptionn = 132 | Patients with at least one potential drug-drug interactions in their prescriptionn = 492 | 
 | --- | --- | --- | 
 | Gender (female) | 105 (79.5) | 386 (78.5) | 
 | Civil status (single) | 61 (46.2) | 259 (52.6) | 
 | Did not work | 102 (77.3) | 416 (84.6) | 
 | Literacy (only elementary school o less) | 67 (54.9) | 266 (62.9) | 
 | Patient age ≥ 60* | 87 (65.9) | 406 (82.5) | 
 | Number of disease ≥ 3* | 73 (55.3) | 396 (80.5) | 
 | Cardiovascular disease* | 43 (32.6) | 403 (81.9) | 
 | Musculoskeletal and joint disorders | 126 (95.5) | 471(95.7) | 
 | Gastrointestinal disease | 48 (36.4) | 205 (41.7) | 
 | Endocrine, alimentary and metabolic disease* | 38 (28.8) | 275 (55.9) | 
 | Pulmonary disease | 8 (6.0) | 31 (6.3) | 
 | Mental disease | 12 (9.1) | 21 (4.3) | 
 | Neurological disease | 11 (8.3) | 40 (8.1) | 
 | Infections and parasitic disease | 30 (22.7) | 88 (17.9) | 
 | Number of medicines ≥ 5* | 50 (37.9) | 383 (77.8) |